Skip to content

Clinical trials

Completed Rhabdomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Status: Completed Country / region: United States Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20031
20043
20051
20065
20077
20084
20092
20106
20117
20126
20133
20144
20157
20164
20175
20184
20192
20203
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)25
Children's Oncology Group10
St. Jude Children's Research Hospital7
Emory University4
Memorial Sloan Kettering Cancer Center4
Eli Lilly and Company3
City of Hope Medical Center2
Eisai Inc.2
Fred Hutchinson Cancer Center2
Massachusetts General Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma93
Sarcoma57
Sarcoma, Ewing48
Osteosarcoma45
Neuroblastoma41
Wilms Tumor25
Neuroectodermal Tumors, Primitive, Peripheral19
Medulloblastoma16
Rhabdoid Tumor16
Sarcoma, Synovial14

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.